Replies to post #544294 on NorthWest Biotherapeutics Inc (NWBO)

[dr_lowenstein]

no I have zero interest in that trial

[DocLee]

Can somebody enlighten me about the difference between "Neoadj PD1 mAB" and "PD-1 mAB" being used in the phase 1 study reported in the message by Skylimit to which this is a reply. I have looked at the trial design in clinicaltrials.gov and cannot determine the answer from that.
PD-1 is clearly Pembrolizumab and ATL-DC is the UCLA produced version of DCVax-L but the only conclusion I can draw is that "Neoadj PD1 mAB" means "placebo for PD1 mAB" . Is this correct and is "neoadj" an accepted code for "placebo"?